COMMUNIQUÉS West-GlobeNewswire

Indi Molecular Appoints Dr. Michael T. Klimas as Senior VP Strategy & Technical Business Development
22/08/2018
CULVER CITY, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Indi Molecular , an emerging life sciences company, announced today that it has appointed Michael T. Klimas Ph.D. as senior vice president of strategy and technical [...]
Chiesi USA, Inc. Named a Best Place to Work
22/08/2018
Triangle Business Journal names Chiesi as one of 50 winners of 2018 Best Places to Work awards CARY, N.C., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), a Cary-based specialty pharmaceutical company, [...]
BioSig Technologies to Present at the MicroCap Leadership Summit
22/08/2018
Santa Monica, CA, Aug. 22, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
American Health Council Recognizes Kathleen Burns, DNP, APRN, ACCNS-AG, ACNS-BC, CEN as “America’s Best Nurse”
22/08/2018
NEW YORK, Aug. 22, 2018 (GLOBE NEWSWIRE) -- The American Health Council is proud to recognize Kathleen Burns, DNP, APRN, ACCNS-AG, ACNS-BC, CEN as “America’s Best Nurse” for her outstanding contributions to the nursing [...]
BioSyent Releases Q2 and H1 2018 Results
22/08/2018
TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30, 2018. Key highlights include: Record [...]
Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc.
22/08/2018
MIAMI , Aug. 22, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that its wholly owned subsidiary PharmCo, LLC has met all three [...]
Easton Pharmaceuticals Begins Discussions to Acquire an Interest in an Operating Casino and Hotel Resort in Greece with Revenues in Excess of 60 Million Euro Per Year
22/08/2018
TORONTO, ON, Aug. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) Announces that it has begun discussions to acquire an interest or participate in the acquisition of an operating [...]
VIVUS to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 5, 2018
22/08/2018
CAMPBELL, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a specialty pharmaceutical company committed to the development and commercialization of innovative therapies focusing on [...]
Merus Announces Formation of a Scientific Advisory Board
22/08/2018
- Key Oncology and Drug Development Professionals to Support Advancement of Merus’ Pipeline of Bispecific Antibodies - UTRECHT, The Netherlands, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical- [...]
Revive Therapeutics Applies To FDA For Orphan Drug Designation of Cannabidiol For Treatment Of Liver Transplantation
22/08/2018
TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive” or the “Company”) , a specialty medical cannabis company, today announced that it has submitted an [...]
Resverlogix Supports Epigenetics Satellite Symposium and Provides Oral Presentation on Apabetalone at the European Society of Cardiology Congress 2018 in Munich
22/08/2018
Key Opinion Leaders gather to discuss: LDL-c: Done Deal, Next Epigenetics? Dr. Ewelina Kulikowski of Resverlogix to present data on the effect of apabetalone on vascular inflammation CALGARY, Alberta, Aug. 22, 2018 ( [...]
Emblem Corp. Reports Second Quarter 2018 Financial Results
22/08/2018
Revenues increase 180% over the quarter ended June 30, 2017 and 18% over Q1 2018 TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), a licensed producer of [...]
Avivagen Announces Vivamune Distribution Agreement for the GTA
22/08/2018
OTTAWA, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
MolecularMD Launches Validated Tumor Mutation Burden Assay for Immuno-Oncology Clinical Trial Services
22/08/2018
PORTLAND, Ore., Aug. 22, 2018 (GLOBE NEWSWIRE) -- MolecularMD today announces it has validated Thermo Fisher Scientific’s Oncomine™ Tumor Mutation Load Assay for clinical research trials to aid immunotherapy drug [...]
JSC “Grindeks” and Latvian Institute of Organic Synthesis sign cooperation agreement
22/08/2018
On Wednesday, August 22, the leaders of Latvian science and industry – JSC “Grindeks” and Latvian Institute of Organic Synthesis (IOS) – strengthened their long-lasting partnership with a new agreement, to reorient from [...]
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2018
22/08/2018
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2018 Biohit Oyj Half Year Financial Report 22 August 2018 at 9:30 am local time (EET) SUMMARY January-June 2018 Net sales EUR 4.9 million (EUR 4.1 million) which grew by 21.1% [...]
argenx announces that AbbVie has exercised its exclusive option to license ARGX-115, a novel immuno-oncology antibody
22/08/2018
Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]
SOLON EIENDOM ASA - Strong results and sales in first half 2018
22/08/2018
Solon Eiendom ASA – Revenue increase of 36 % in the first half of 2018 compared to first half 2017. Total EBITDA (NGAAP) of NOK 156 million in the first half of 2018. (Oslo, Norway, 22 August 2018) Solon Eiendom ASA ( [...]
Saniona publishes its interim report for the second quarter 2018
22/08/2018
PRESS RELEASE August 22, 2018 Financial highlights H1 2018 (H1 2017) Net revenues were SEK 8.1 M (11.9 M) EBIT was SEK -39.9 M (-25.4 M) Net profit/loss was SEK -33.0 M (-21.1 M) Earnings per share were SEK -1.51 (-1.00 [...]

Pages